Clinical Trials Logo

Irreversible Pulpitis clinical trials

View clinical trials related to Irreversible Pulpitis.

Filter by:

NCT ID: NCT05733468 Active, not recruiting - Clinical trials for Irreversible Pulpitis

TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars

Start date: July 1, 2022
Phase: Phase 4
Study type: Interventional

To evaluate and compare the clinical and radiographic success rate of TheraCal LC and MTA for coronal pulpotomy of mature permanent molar in 9-14 year children.

NCT ID: NCT05622266 Recruiting - Clinical trials for Irreversible Pulpitis

Effectiveness of Pulpotomy in the Management of Mature Permanent Tooth With Irreversible Pulpits

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This study is to evaluate the effectiveness of pulpotomy in mature permanent tooth with irreversible pulpits, and compare the clinical efficacy of pulpotomy and root canal therapy.

NCT ID: NCT05568563 Completed - Clinical trials for Irreversible Pulpitis

Comparison of Effectiveness of Pre-cooling With Ethyl Chloride Versus Honey

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Comparing Pre-cooling with Ethyl Chloride versus Honey in Alleviating Intra-oral injection pain in Adult patients

NCT ID: NCT05441995 Not yet recruiting - Pain Clinical Trials

Cryotherapy Efficacy During Pulp Therapy of the Mandibular First Permanent Molars in Children

Start date: June 2022
Phase: N/A
Study type: Interventional

The aim of the study is to assess the efficacy of cryotherapy application on the success of inferior alveolar nerve block (IANB) in reducing pain during pulp therapy of the mandibular first permanent molars with irreversible pulpitis (IP) in children age from 7 to 16 years. The null hypothesis (H0) supposed no difference in pain intensity during pulp therapy of primary molars with IP anesthetized with IANB with and without cryotherapy application. The secondary aim was to evaluate the children's behavior before and after pulpectomy in the two groups.

NCT ID: NCT05427851 Active, not recruiting - Clinical trials for Irreversible Pulpitis

Diode Laser Pulpotomy of Mature Permanent Molars With Irreversible Pulpitis

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

Thirty six patients are included in this study. For each patient, a pulpotomy procedure is performed.

NCT ID: NCT05349929 Not yet recruiting - Clinical trials for Irreversible Pulpitis

Analgesic Effect of Anahil and Ibuprofen on Pain After Root Canal Therapy in Patients With Pulpitis of the Molars in Qazvin(a City in Iran)

Start date: May 2022
Phase: Phase 2
Study type: Interventional

Hypothesis: 0: The analgesic effect of Ibuprofen and Anahil would be the same in reducing the pain after root canal therapy. 1: Ibuprofen shows higher potency to reduce the pain after root canal therapy. 1: Anahil shows higher potency to reduce the pain after root canal therapy. 1. combination of the Anahil and Ibuprofen would have more effective results in reducing the pain post endodontic treatment.

NCT ID: NCT05306431 Completed - Clinical trials for Irreversible Pulpitis

Comparison of Antimicrobial Action of Sodium Hypochlorite and Polyhexamethylene Biguanide as Root Canal Irrigants

Start date: June 1, 2022
Phase: Phase 2
Study type: Interventional

The aim of this randomized clinical trial is to compare the antibacterial effects of sodium hypochlorite (NaOCl) and Polyhexamethylene biguanide during root canal treatment .

NCT ID: NCT05279820 Recruiting - Clinical trials for Irreversible Pulpitis

Comparative Study of the Outcome of Partial and Full Pulpotomy in Irreversible Pulpits

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aims at comparing the outcome of partial pulpotomy and full pulpotomy in the management of carious pulp exposures in permanent teeth with a clinical diagnosis of irreversible pulpits. The primary outcome is resolution of symptoms and the secondary outcome is clinical and radiographic normality at 1 and 2 years follow up. The study design will be a double blind randomized clinical trial.

NCT ID: NCT05277246 Not yet recruiting - Clinical trials for Irreversible Pulpitis

Effect of Using Different Concentrations of NaOCI on IL-8 Level

Start date: March 20, 2022
Phase: N/A
Study type: Interventional

The objective is to compare various concentrations of NAOCL during Root canal treatment and their effect on IL-8 at the gingival crevicular fluid. Despite the current advancement of beneficial endodontic diagnostic methods, such as pulp sensitivity tests and periapical radiographs, clinical outcomes do not always correspond with the arrangement of the histological condition of the pulp. At this point, the need for other ways to help diagnose pathological pulpal disease has arisen. This situation has influenced researchers to use molecular evaluation as an alternative route in endodontic diagnosis. Biomarkers, functional at the cellular and molecular level, are crucial elements within the pathological process. Detection of molecular markers is considered an ancillary method for diagnosing the pathological condition of the pulp tissue.An increase in inflammatory cells in the carious or traumatized dentinal pulp complex has been reported. In the presence of bacteria, immune cells produce interleukin-6 (IL6), interleukin-8 (CXCL8), and tumor necrosis factor-alpha (TNF) in the pulp. Interleukin-8 is frequently expressed in endothelial cells of inflamed pulp and rarely in the normal pulp. Karapanou et al. (2008) revealed that interleukin-8 was more greatly released in teeth with irreversible pulpitis than in the control group in a research in which gingival crevicular fluid with acute pulpitis was analyzed. the pulp tissue and gingival crevicular fluid of teeth with symptomatic irreversible pulpitis were dramatically augmented by these indicators compared with healthy teeth. Furthermore, they concluded that the levels of NKA, SP, IL8, and MMP8 in the gingival crevicular fluid decreased one week after endodontic treatment of teeth with pulpitis. Subsequently, it has been reported that patients with symptomatic irreversible pulpitis with high initial pain scores have higher levels of SP, IL8, and MMP8 in the pulp tissue samples than those with low pain scores.It is recommended to use NaOCl concentration between 0.5% and 5.25% as an irrigation solution in root canal treatment (6). The effectiveness of NaOCl increases with increasing concentration, but its toxicity is known to be proportional to concentration. Therefore, there is no consensus on the optimal concentration of NaOCL. When articles were reviewed, it was found that inflammation of the pulp and biomarker levels are correlated. For this reason, we believe that whether or not NaOCl solution at various concentrations causes inflammation can be analyzed by the level of IL-8. Upon review of the literature, it was found that no studies investigated the influence of NaOCl solution on biomarkers in the gingival crevicular fluid. The research described below contributes to the literature on the optimal concentration of NaOCl to use.

NCT ID: NCT05190406 Recruiting - Clinical trials for Irreversible Pulpitis

Success and Quality of Life Following Complete Pulpotomy and Root Canal Treatment

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the Success and quality of life following complete pulpotomy and root canal treatment in teeth with clinical signs indicative of irreversible pulpitis.